225 related articles for article (PubMed ID: 18095019)
21. [Anti-restenosis study on a new drug eluting stent].
Zhao A; Zhang H; Huang N; Zhang B; Yang K; Li Z; Zhao H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):856-9, 878. PubMed ID: 18788296
[TBL] [Abstract][Full Text] [Related]
22. A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.
Krucoff MW; Kereiakes DJ; Petersen JL; Mehran R; Hasselblad V; Lansky AJ; Fitzgerald PJ; Garg J; Turco MA; Simonton CA; Verheye S; Dubois CL; Gammon R; Batchelor WB; O'Shaughnessy CD; Hermiller JB; Schofer J; Buchbinder M; Wijns W;
J Am Coll Cardiol; 2008 Apr; 51(16):1543-52. PubMed ID: 18420096
[TBL] [Abstract][Full Text] [Related]
23. Self-expanding nitinol renal artery stents: comparison of safety and efficacy of bare versus Polyzene-F nanocoated stents in a porcine model.
Kurz P; Stampfl U; Christoph P; Henn C; Satzl S; Radeleff B; Berger I; Richter GM
Cardiovasc Intervent Radiol; 2011 Feb; 34(1):139-48. PubMed ID: 20976452
[TBL] [Abstract][Full Text] [Related]
24. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
[TBL] [Abstract][Full Text] [Related]
25. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
[TBL] [Abstract][Full Text] [Related]
26. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent.
Xu B; Zhang Q; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Hong T; Li JP; Chen JL; Huo Y; Gao RL; Shen WF
Chin Med J (Engl); 2008 Mar; 121(6):492-7. PubMed ID: 18364131
[TBL] [Abstract][Full Text] [Related]
27. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
Jabara R; Chronos N; Robinson K
Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
[TBL] [Abstract][Full Text] [Related]
28. Cre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulation.
Moretti C; Lolli V; Perona G; Vignolini MC; Cabiale K; Falzone M; Galloni M
EuroIntervention; 2012 Jan; 7(9):1087-94. PubMed ID: 22130128
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of cobalt chromium alloy based sirolimus-eluting stent with bioabsorbable polymer in porcine model.
Wu YZ; Shen L; Wang QB; Hu X; Xie J; Qian JY; Ge JB
Chin Med J (Engl); 2012 Mar; 125(6):983-9. PubMed ID: 22613518
[TBL] [Abstract][Full Text] [Related]
30. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
[TBL] [Abstract][Full Text] [Related]
31. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
32. Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model.
Wilson GJ; Polovick JE; Huibregtse BA; Poff BC
Cardiovasc Res; 2007 Nov; 76(2):361-72. PubMed ID: 17716637
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI).
Escolar E; Mintz GS; Popma J; Michalek A; Kim SW; Mandinov L; Koglin J; Stone G; Ellis SG; Grube E; Dawkins KD; Weissman NJ
Am J Cardiol; 2007 Aug; 100(4):621-6. PubMed ID: 17697817
[TBL] [Abstract][Full Text] [Related]
34. Short-, mid-, and long-term effects of a polymer-free tacrolimus-eluting stent in a porcine coronary model.
Prunotto M; Vignolini C; Lolli V; Black A; Gaggianesi S; Santarelli A; Galloni M
J Biomed Mater Res A; 2009 Mar; 88(4):872-9. PubMed ID: 18360883
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
36. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.
Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A
Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624
[TBL] [Abstract][Full Text] [Related]
37. Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform.
Thompson CA; Huibregtse B; Poff B; Wilson GJ
Catheter Cardiovasc Interv; 2009 Apr; 73(5):597-604. PubMed ID: 19180652
[TBL] [Abstract][Full Text] [Related]
38. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
39. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
40. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents.
Otsuka Y; Chronos NA; Apkarian RP; Robinson KA
J Invasive Cardiol; 2007 Feb; 19(2):71-6. PubMed ID: 17268041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
